BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Braunersreuther V, Viviani GL, Mach F, Montecucco F. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol 2012; 18(8): 727-735 [PMID: 22371632 DOI: 10.3748/wjg.v18.i8.727]
URL: https://www.wjgnet.com/1007-9327/full/v18/i8/727.htm
Number Citing Articles
1
梦君 廖. Curcumin and Nonalcoholic Fatty Liver DiseaseTraditional Chinese Medicine 2019; 8(01): 61 doi: 10.12677/TCM.2019.81013
2
Calvin C. Chan, Michelle S.M.A. Damen, Pablo C. Alarcon, Joan Sanchez-Gurmaches, Senad Divanovic. Inflammation and Immunity: From an Adipocyte's PerspectiveJournal of Interferon & Cytokine Research 2019; 39(8): 459 doi: 10.1089/jir.2019.0014
3
K. Dvorshchenko. Changes of energy balance of rat liver and pancreas upon gastric hypoacidity and search of approaches for its recoveryBulletin of Taras Shevchenko National University of Kyiv. Series: Biology 2014; 68(3): 54 doi: 10.17721/1728_2748.2014.68.54-57
4
Yara Alenazi, Kamayani Singh, Graham Davies, James R. O. Eaton, Philip Elders, Akane Kawamura, Shoumo Bhattacharya. Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsetsScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24568-9
5
Stephanie Breher-Esch, Nishika Sahini, Anna Trincone, Christin Wallstab, Jürgen Borlak. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver diseaseBMC Medical Genomics 2018; 11(1) doi: 10.1186/s12920-018-0438-7
6
Thing-Fong Tzeng, Shorong-Shii Liou, Chia Ju Chang, I-Min Liu. Zerumbone, a Natural Cyclic Sesquiterpene ofZingiber zerumbetSmith, Attenuates Nonalcoholic Fatty Liver Disease in Hamsters Fed on High-Fat DietEvidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/303061
7
Yancheng Song, Jan Zhang, Hexiang Wang, Dong Guo, Chentong Yuan, Bo Liu, Hao Zhong, Dongmei Li, Yu Li. A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver diseaseAdipocyte 2021; 10(1): 424 doi: 10.1080/21623945.2021.1970341
8
Lindsei K. Sarna, Yaw L. Siow, Karmin O. The CBS/CSE system: a potential therapeutic target in NAFLD?Canadian Journal of Physiology and Pharmacology 2015; 93(1): 1 doi: 10.1139/cjpp-2014-0394
9
Antonella Mosca, Annalisa Crudele, Antonella Smeriglio, Maria Rita Braghini, Nadia Panera, Donatella Comparcola, Arianna Alterio, Maria Rita Sartorelli, Giulia Tozzi, Massimiliano Raponi, Domenico Trombetta, Anna Alisi. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLDDigestive and Liver Disease 2021; 53(9): 1154 doi: 10.1016/j.dld.2020.09.021
10
Gyongyi Szabo, Johanna Bruneau. Viral Hepatitis2013; : 13 doi: 10.1002/9781118637272.ch2
11
José F. Català-Senent, Marta R. Hidalgo, Marina Berenguer, Gopanandan Parthasarathy, Harmeet Malhi, Pablo Malmierca-Merlo, María de la Iglesia-Vayá, Francisco García-García. Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studiesBiology of Sex Differences 2021; 12(1) doi: 10.1186/s13293-021-00368-1
12
María Eugenia Inzaugarat, Elena De Matteo, Placida Baz, Diego Lucero, Cecilia Claudia García, Esteban Gonzalez Ballerga, Jorge Daruich, Juan Antonio Sorda, Miriam Ruth Wald, Alejandra Claudia Cherñavsky, Vida A. Dennis. New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humansPLOS ONE 2017; 12(3): e0172900 doi: 10.1371/journal.pone.0172900
13
Yanyan Wang, Xiqiao Zhou, Derrick Zhao, Xuan Wang, Emily C. Gurley, Runping Liu, Xiaojiaoyang Li, Phillip B. Hylemon, Weidong Chen, Huiping Zhou, Gianfranco D. Alpini. Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytesPLOS ONE 2020; 15(5): e0232630 doi: 10.1371/journal.pone.0232630
14
Florian Padberg, Henrik Hering, Andreas Luch, Sebastian Zellmer. Indirect co-cultivation of HepG2 with differentiated THP-1 cells induces AHR signalling and release of pro-inflammatory cytokinesToxicology in Vitro 2020; 68: 104957 doi: 10.1016/j.tiv.2020.104957
15
Jingjing Cai, Xiao‐Jing Zhang, Hongliang Li. The Role of Innate Immune Cells in Nonalcoholic SteatohepatitisHepatology 2019; 70(3): 1026 doi: 10.1002/hep.30506
16
Hyeonji Kim, Kippeum Lee, Ju-Yeon Kim, Jae-Jung Shim, Junghyun Lim, Joo-Yun Kim, Jung-Lyoul Lee. Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse ModelMicroorganisms 2023; 11(10): 2466 doi: 10.3390/microorganisms11102466
17
Claudia Isabel García-Berumen, Manuel Alejandro Vargas-Vargas, Omar Ortiz-Avila, Rosa María Piña–Zentella, Minerva Ramos-Gómez, María del Consuelo Figueroa–García, Ricardo Mejía-Zepeda, Alain Raimundo Rodríguez–Orozco, Alfredo Saavedra–Molina, Christian Cortés-Rojo. Avocado oil alleviates non-alcoholic fatty liver disease by improving mitochondrial function, oxidative stress and inflammation in rats fed a high fat–High fructose dietFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1089130
18
Sylwia Ziolkowska, Agata Binienda, Maciej Jabłkowski, Janusz Szemraj, Piotr Czarny. The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2021; 22(20): 11128 doi: 10.3390/ijms222011128
19
Samah Alharbi. Exogenous administration of unacylated ghrelin attenuates hepatic steatosis in high-fat diet-fed rats by modulating glucose homeostasis, lipogenesis, oxidative stress, and endoplasmic reticulum stressBiomedicine & Pharmacotherapy 2022; 151: 113095 doi: 10.1016/j.biopha.2022.113095
20
Saika Manzoor, Mohd Ashraf Ganie, Shajrul Amin, Zaffar A Shah, Imtiyaz A Bhat, S. Douhath Yousuf, Humira Jeelani, Iram A Kawa, Qudsia Fatima, Fouzia Rashid. Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational studyScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46644-4
21
Roberta Budriesi, Fabio Vivarelli, Donatella Canistro, Rita Aldini, Clara Babot Marquillas, Ivan Corazza, Romana Fato, Silvia Cirillo, Christian Bergamini, Antonia D’Errico, Cristiano Bolchi, Monica Cevenini, Alessio Degiovanni, Maria Frosini, Luca Camarda, Alberto Chiarini, Matteo Micucci, Paula B. Andrade. Liver and intestinal protective effects of Castanea sativa Mill. bark extract in high-fat diet ratsPLOS ONE 2018; 13(8): e0201540 doi: 10.1371/journal.pone.0201540
22
Jingxuan Zhou, Nanhai Zhang, Adil Aldhahrani, Mohamed Mohamed Soliman, Liebing Zhang, Feng Zhou. Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammationFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.956688
23
Dongwei Jia, Fangfang Duan, Peike Peng, Linlin Sun, Xiaojuan Liu, Lan Wang, Weicheng Wu, Yuanyuan Ruan, Jianxin Gu, Anna Alisi. Up-Regulation of RACK1 by TGF-β1 Promotes Hepatic Fibrosis in MicePLoS ONE 2013; 8(3): e60115 doi: 10.1371/journal.pone.0060115
24
Yoon-Seok Roh, Ekihiro Seki. Obesity, Fatty Liver and Liver CancerAdvances in Experimental Medicine and Biology 2018; 1061: 45 doi: 10.1007/978-981-10-8684-7_4
25
Brett M. McGettigan, Rachel H. McMahan, Yuhuan Luo, Xiaoxin X. Wang, David J. Orlicky, Cara Porsche, Moshe Levi, Hugo R. Rosen. Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver DiseaseJournal of Biological Chemistry 2016; 291(44): 23058 doi: 10.1074/jbc.M116.731042
26
Yanbo Fan, Haocheng Lu, Yanhong Guo, Tianqing Zhu, Minerva T. Garcia-Barrio, Zhisheng Jiang, Cristen J. Willer, Jifeng Zhang, Y. Eugene Chen. Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in MiceGastroenterology 2016; 150(5): 1208 doi: 10.1053/j.gastro.2016.01.005
27
Xiangjin Xu, Wenqing Wang, Lu Lin, Pin Chen. Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD ratsTissue and Cell 2020; 66: 101382 doi: 10.1016/j.tice.2020.101382
28
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, Nitesh Kumar, C. Mallikarjuna Rao. Epigenetics in NAFLD/NASH: Targets and therapyPharmacological Research 2021; 167: 105484 doi: 10.1016/j.phrs.2021.105484
29
Min Cheol Kim, Kyeong Ok Kim, Min Kyu Kang. Prevalence and associated risk of advanced colorectal neoplasia in adults with sarcopeniaThe Korean Journal of Internal Medicine 2022; 37(2): 294 doi: 10.3904/kjim.2020.569
30
Veeral Ajmera, Emily R. Perito, Nathan M. Bass, Norah A. Terrault, Katherine P. Yates, Ryan Gill, Rohit Loomba, Anna Mae Diehl, Bradley E. Aouizerat. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver diseaseHepatology 2017; 65(1): 65 doi: 10.1002/hep.28776
31
Qing Shi, Rong Shen, Chao-Fu Wang, Xing Fan, Ying Qian, Bin-Shen Ou-Yang, Yan Zhao, Christophe Leboeuf, Anne Janin, Shu Cheng, Li Wang, Wei-Li Zhao. Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL PatientsMediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/7960907
32
Md. Abdul Kader, Md. Masuder Rahman, Shahin Mahmud, Md. Sharif Khan, Shamsunnahar Mukta, Fatama Tous Zohora. A comparative study on the Antihyperlipidemic and antibacterial potency of the shoot and flower extracts of Melastoma malabathricum Linn'sClinical Phytoscience 2023; 9(1) doi: 10.1186/s40816-023-00355-6
33
Un Jung, Yun-Young Cho, Myung-Sook Choi. Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese MiceNutrients 2016; 8(5): 305 doi: 10.3390/nu8050305
34
Hyo-Joon Yang, Yoosoo Chang, Soo-Kyung Park, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Seungho Ryu, Chong Il Sohn. Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux EsophagitisDigestive Diseases and Sciences 2017; 62(12): 3605 doi: 10.1007/s10620-017-4805-6
35
Simon Ströbel, Radina Kostadinova, Katia Fiaschetti-Egli, Jana Rupp, Manuela Bieri, Agnieszka Pawlowska, Donna Busler, Thomas Hofstetter, Katarzyna Sanchez, Sue Grepper, Eva Thoma. A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidatesScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01951-7
36
Timothy D. Rohrbach, Amon Asgharpour, Melissa A. Maczis, David Montefusco, L. Ashley Cowart, Pierre Bedossa, Arun J. Sanyal, Sarah Spiegel. FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in miceJournal of Lipid Research 2019; 60(7): 1311 doi: 10.1194/jlr.M093799
37
L. E. Tabikhanova, L. P. Osipova, T. V. Churkina, S. S. Kovalev, M. L. Filipenko, E. N. Voronina. Increased Frequencies of the ‒174G and ‒572C IL6 Alleles in Populations of Indigenous Peoples of Siberia Compared to RussiansMolecular Biology 2023; 57(2): 329 doi: 10.1134/S002689332302019X
38
Joost Boeckmans, Karolien Buyl, Alessandra Natale, Valerie Vandenbempt, Steven Branson, Veerle De Boe, Vera Rogiers, Joery De Kock, Robim M. Rodrigues, Tamara Vanhaecke. Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASHPharmacological Research 2019; 144: 377 doi: 10.1016/j.phrs.2019.04.016
39
Lili Chen, Qianfei Zhang, Chang Yu, Fang Wang, Xiaoni Kong. Functional roles of CCL5/RANTES in liver diseaseLiver Research 2020; 4(1): 28 doi: 10.1016/j.livres.2020.01.002
40
Shuhei Yoshida, Masashi Fujita, Teruhide Ishigame, Yasuyuki Kobayashi, Yuya Sumichika, Kenji Saito, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Hiroshi Watanabe, Hiroshi Yoshida, Shigeru Marubashi, Yuko Hashimoto, Hiromasa Ohira, Kiyoshi Migita. Case report: Unusual development of hepatocellular carcinoma during immunosuppressive treatments against rheumatoid arthritis overlapping Sjögren’s syndrome; cirrhotic steatohepatitis with liver inflammation and fibrosis lurks in autoimmune disordersFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1089492
41
Michelle S. M. A. Damen, Traci E. Stankiewicz, Se-Hyung Park, Robert N. Helsley, Calvin C. Chan, Maria E. Moreno-Fernandez, Jessica R. Doll, Sara Szabo, De’Broski R. Herbert, Samir Softic, Senad Divanovic. Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelaeInternational Journal of Obesity 2021; 45(11): 2377 doi: 10.1038/s41366-021-00902-6
42
Giuseppina Palladini, Laura Di Pasqua, Clarissa Berardo, Veronica Siciliano, Plinio Richelmi, Barbara Mannucci, Anna Croce, Vittoria Rizzo, Stefano Perlini, Mariapia Vairetti, Andrea Ferrigno. Fatty Acid Desaturase Involvement in Non-Alcoholic Fatty Liver Disease Rat Models: Oxidative Stress Versus MetalloproteinasesNutrients 2019; 11(4): 799 doi: 10.3390/nu11040799
43
Luis Fontana, Julio Plaza-Díaz, Paula Robles-Bolívar, Héctor Valente-Godínez, María José Sáez-Lara, Francisco Abadía-Molina, Carolina Gómez-Llorente, Ángel Gil, Ana I. Álvarez-Mercado. Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Leprfa/fa RatsNutrients 2021; 13(1): 202 doi: 10.3390/nu13010202
44
M Masudur Rahman, Md Golam Kibria, Hasina Begum, Mazhar Haque, Nigar Sultana, Mahfuza Akhter, A H M Rowshon, Faruqe Ahmed, Mahmud Hasan. Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South AsiaBMJ Open Gastroenterology 2020; 7(1): e000535 doi: 10.1136/bmjgast-2020-000535
45
Sabira Mohammed, Evan H. Nicklas, Nidheesh Thadathil, Ramasamy Selvarani, Gordon H. Royce, Michael Kinter, Arlan Richardson, Sathyaseelan S. Deepa. Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stressFree Radical Biology and Medicine 2021; 164: 315 doi: 10.1016/j.freeradbiomed.2020.12.449
46
Anle Xu, Fei Han, Yuan Zhang, Tao Zhou, Tianxiang Gao. Comparative Transcriptomic Analyses Revealed the Effects of Poly (I:C) on the Liver and Spleen of Argyrosomus japonicusInternational Journal of Molecular Sciences 2022; 23(17): 9801 doi: 10.3390/ijms23179801
47
Jarren R. Oates, Melanie C. McKell, Maria E. Moreno-Fernandez, Michelle S. M. A. Damen, George S. Deepe, Joseph E. Qualls, Senad Divanovic. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac AttackFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02893
48
Xiao-Han Tang, Marta Melis, Changyuan Lu, Andrew Rappa, Tuo Zhang, Jose Jessurun, Steven S. Gross, Lorraine J. Gudas. A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver diseaseJournal of Biological Chemistry 2021; 297(6): 101331 doi: 10.1016/j.jbc.2021.101331
49
L. Perez-Martinez, P. Perez-Matute, J. Aguilera-Lizarraga, S. Rubio-Mediavilla, J. Narro, E. Recio, L. Ochoa-Callejero, J.-A. Oteo, J.-R. Blanco. Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)Journal of Antimicrobial Chemotherapy 2014; 69(7): 1903 doi: 10.1093/jac/dku071
50
Marina Chaves de Oliveira, Zélia Menezes-Garcia, Raquel Duque do Nascimento Arifa, Talles Prosperi de Paula, João Marcus Oliveira Andrade, Sérgio Henrique Sousa Santos, Gustavo Batista de Menezes, Danielle da Glória de Souza, Mauro Martins Teixeira, Adaliene Versiani Matos Ferreira. Platelet-activating factor modulates fat storage in the liver induced by a high-refined carbohydrate-containing dietThe Journal of Nutritional Biochemistry 2015; 26(9): 978 doi: 10.1016/j.jnutbio.2015.04.004
51
Natalia Zhelezniakova, Anastasiia Rozhdestvenska. IL-1β and IL-10: diagnostic and prognostic potential of cytokines in the assessment of progression of non-alcoholic fatty liver disease in patients with hypertensionEUREKA: Health Sciences 2021; (5): 17 doi: 10.21303/2504-5679.2021.001854
52
Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signalingBiomedicine & Pharmacotherapy 2020; 131: 110785 doi: 10.1016/j.biopha.2020.110785
53
Lorna Ewart, Eva-Maria Dehne, Kristin Fabre, Susan Gibbs, James Hickman, Ellinor Hornberg, Magnus Ingelman-Sundberg, Kyung-Jin Jang, David R. Jones, Volker M. Lauschke, Uwe Marx, Jerome T. Mettetal, Amy Pointon, Dominic Williams, Wolfram-Hubertus Zimmermann, Peter Newham. Application of Microphysiological Systems to Enhance Safety Assessment in Drug DiscoveryAnnual Review of Pharmacology and Toxicology 2018; 58(1): 65 doi: 10.1146/annurev-pharmtox-010617-052722
54
Tao Zeng, Cui-Li Zhang, Xiu-Lan Zhao, Ke-Qin Xie. Pentoxifylline for the treatment of nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2014; 26(6): 646 doi: 10.1097/MEG.0000000000000068
55
L. F. Torres, B. Cogliati, R. Otton. Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse ModelOxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/4168380
56
Hammad Ahmed, Muhammad Ihtisham Umar, Salman Imran, Faraza Javaid, Shahzada Khurram Syed, Romana Riaz, Waseem Hassan. TGF-β1 signaling can worsen NAFLD with liver fibrosis backdropExperimental and Molecular Pathology 2022; 124: 104733 doi: 10.1016/j.yexmp.2021.104733
57
Doyoung Kwon, Sou Hyun Kim, Seung Won Son, Jinuk Seo, Tae Bin Jeong, Kyung-Mi Kim, Jae-Chul Jung, Mi Sook Jung, Yun-Hee Lee, Young-Suk Jung. Germinated Soybean Embryo Extract Ameliorates Fatty Liver Injury in High-Fat Diet-Fed Obese MicePharmaceuticals 2020; 13(11): 380 doi: 10.3390/ph13110380
58
Yanqin Du, Tanvi Khera, Zhaoli Liu, Magdalena Tudrujek-Zdunek, Anna Dworzanska, Markus Cornberg, Cheng-Jian Xu, Krzysztof Tomasiewicz, Heiner Wedemeyer. Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV InfectionBiomedicines 2023; 11(6): 1529 doi: 10.3390/biomedicines11061529
59
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesWorld Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
60
Sara Youssry, Maher A. Kamel. Effect of folate supplementation on immunological and autophagy markers in experimental nonalcoholic fatty liver diseaseEuropean Cytokine Network 2019; 30(4): 135 doi: 10.1684/ecn.2019.0437
61
Feng Xiao, Shar L. Waldrop, Steve F. Bronk, Gregory J. Gores, Laurie S. Davis, Gordan Kilic. Lipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cellsPurinergic Signalling 2015; 11(3): 347 doi: 10.1007/s11302-015-9456-5
62
Victoria L. Gadd, Preya J. Patel, Sara Jose, Leigh Horsfall, Elizabeth E. Powell, Katharine M. Irvine, Alexandre Boissonnas. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic InflammationPLOS ONE 2016; 11(6): e0157771 doi: 10.1371/journal.pone.0157771
63
Simon Haefliger, Dina Milowich, Amedeo Sciarra, Mounir Trimeche, Justine Bouilly, Julie Kaiser, Stephanie Volpi, Jean-Philippe Brouland, Christine Sempoux, Laurence de Leval. Primary hepatic marginal B cell lymphoma of mucosa-associated lymphoid tissue (MALT) and non-alcoholic steatohepatitis (NASH): more than a coincidence?Annals of Hematology 2019; 98(6): 1513 doi: 10.1007/s00277-018-3565-5
64
Shaniko Shini, Agim Shini, Wayne L. Bryden. Unravelling fatty liver haemorrhagic syndrome: 2. Inflammation and pathophysiologyAvian Pathology 2020; 49(2): 131 doi: 10.1080/03079457.2019.1682119
65
Naveen Kaushal, Megha Gupta, Era Kulshreshtha. Hempseed (Cannabis sativa) lipid fractions alleviate high-fat diet-induced fatty liver disease through regulation of inflammation and oxidative stressHeliyon 2020; 6(7): e04422 doi: 10.1016/j.heliyon.2020.e04422
66
Jinchunzi Yang, Neira Sáinz, Elisa Félix-Soriano, Eva Gil-Iturbe, Rosa Castilla-Madrigal, Marta Fernández-Galilea, J. Alfredo Martínez, María J. Moreno-Aliaga. Effects of Long-Term DHA Supplementation and Physical Exercise on Non-Alcoholic Fatty Liver Development in Obese Aged Female MiceNutrients 2021; 13(2): 501 doi: 10.3390/nu13020501
67
Ernest C. Lynch, Zhimin Liu, Lin Liu, Xian Wang, Ke K. Zhang, Linglin Xie, Catherine Mounier. Disrupting Osr1 expression promoted hepatic steatosis and inflammation induced by high-fat diet in the mouse modelPLOS ONE 2022; 17(6): e0268344 doi: 10.1371/journal.pone.0268344
68
Yen-Chun Koh, Yen-Cheng Lin, Pei-Sheng Lee, Ting-Jang Lu, Kai-Yi Lin, Min-Hsiung Pan. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extractsFood & Function 2020; 11(9): 7545 doi: 10.1039/D0FO01405B
69
Anle Xu, Jingbo Shang-Guan, Zhongbao Li, Zhangfan Huang, Shenjia Shi, Youling Ye. Effects of dietary vitamin E on the growth performance, immunity and digestion of Epinephelus fuscoguttatus ♀ × Epinephelus lanceolatus ♂ by physiology, pathology and RNA-seqAquaculture 2023; 575: 739752 doi: 10.1016/j.aquaculture.2023.739752
70
Jiangning Yin, Hanqing Wang, Guoyuan Lu. Umbelliferone alleviates hepatic injury in diabetic db/db mice via inhibiting inflammatory response and activating Nrf2-mediated antioxidantBioscience Reports 2018; 38(4) doi: 10.1042/BSR20180444
71
Hung-Jen Lu, Thing-Fong Tzeng, Shorong-Shii Liou, Chia Ju Chang, Cheng Yang, Ming-Chang Wu, I-Min Liu. Ruscogenin Ameliorates Experimental Nonalcoholic Steatohepatitis via Suppressing Lipogenesis and Inflammatory PathwayBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/652680
72
Mengliu Yang, Jihuan Dai, Yanjun Jia, Langquzhen Suo, Shengbing Li, Yunsong Guo, Hua Liu, Ling Li, Gangyi Yang. Overexpression of juxtaposed with another zinc finger gene 1 reduces proinflammatory cytokine release via inhibition of stress‐activated protein kinases and nuclear factor‐κBThe FEBS Journal 2014; 281(14): 3193 doi: 10.1111/febs.12853
73
Teresa Vezza, José Garrido-Mesa, Patricia Diez-Echave, Laura Hidalgo-García, Antonio J. Ruiz-Malagón, Federico García, Manuel Sánchez, Marta Toral, Miguel Romero, Juan Duarte, Enrique Guillamón, Alberto Baños Arjona, Rocío Moron, Julio Galvez, Alba Rodríguez-Nogales, María Elena Rodríguez-Cabezas. Allium-Derived Compound Propyl Propane Thiosulfonate (PTSO) Attenuates Metabolic Alterations in Mice Fed a High-Fat Diet through Its Anti-Inflammatory and Prebiotic PropertiesNutrients 2021; 13(8): 2595 doi: 10.3390/nu13082595
74
Peter P. Sordillo, Laura A. Sordillo. Biophotonics, Tryptophan and Disease2022; : 81 doi: 10.1016/B978-0-12-822790-9.00011-5
75
Andra-Iulia Suceveanu, Sergiu-Ioan Micu, Anca Pantea Stoian, Laura Mazilu, Viorel Gherghina, Irinel Raluca Parepa, Adrian-Paul Suceveanu. Essentials of Non-Alcoholic Fatty Liver Disease2023; : 59 doi: 10.1007/978-3-031-33548-8_5
76
ZHOU ZHOU, YING-CHAO LIU, XIAO-MEI CHEN, FU-QIANG LI, XIAO-JUAN TONG, YUE-PING DING, CUI-LAN TANG. Treatment of experimental non-alcoholic steatohepatitis by targeting α7 nicotinic acetylcholine receptor-mediated inflammatory responses in miceMolecular Medicine Reports 2015; 12(5): 6925 doi: 10.3892/mmr.2015.4318
77
Mohamed A. Abdelmegeed, Atrayee Banerjee, Seong-Ho Yoo, Sehwan Jang, Frank J. Gonzalez, Byoung-Joon Song. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitisJournal of Hepatology 2012; 57(4): 860 doi: 10.1016/j.jhep.2012.05.019
78
Gong‐Rak Lee, Hye In Lee, Narae Kim, Jiae Lee, Minjeong Kwon, Ye Hee Kang, Hyeong Ju Song, Chang‐Yeol Yeo, Woojin Jeong. Dynein light chain LC8 alleviates nonalcoholic steatohepatitis by inhibiting NF‐κB signaling and reducing oxidative stressJournal of Cellular Physiology 2022; 237(9): 3554 doi: 10.1002/jcp.30811
79
Darmadi Darmadi, Riska Habriel Ruslie. Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD)Romanian Journal of Internal Medicine 2021; 59(1): 66 doi: 10.2478/rjim-2020-0029
80
Chong Peng, Jing Li, Xuehong Ke, Fengbin Liu, Ke-er Huang. In silico and in vivo demonstration of the regulatory mechanism of Qi-Ge decoction in treating NAFLD Annals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2200258
81
Long Li, Chaoli Duan, Yan Zhao, Xiaofang Zhang, Hongyan Yin, Tianxi Wang, Caoxin Huang, Suhuan Liu, Shuyu Yang, Xuejun Li. Preventive effects of interleukin-6 in lipopolysaccharide/ d -galactosamine induced acute liver injury via regulating inflammatory response in hepatic macrophagesInternational Immunopharmacology 2017; 51: 99 doi: 10.1016/j.intimp.2017.08.009
82
Roberto Catanzaro, Federica Calabrese, Sergio Occhipinti, Maria Grazia Anzalone, Angelo Italia, Michele Milazzo, Francesco Marotta. Nonalcoholic Fatty Liver Disease Increases Risk for Gastroesophageal Reflux SymptomsDigestive Diseases and Sciences 2014; 59(8): 1939 doi: 10.1007/s10620-014-3113-7
83
Yanmei Zhang, Xiaoxiao Ge, Yongqing Li, Bingyang Zhang, Peijun Wang, Mingju Hao, Peng Gao, Yueyi Zhao, Tao Sun, Sumei Lu, Wanshan Ma. TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitisLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01458-0
84
Edenil Costa Aguilar, Weslley Fernandes-Braga, Paola Caroline Lacerda Leocádio, Gianne Paul Campos, Virginia Soares Lemos, Rafael Pires de Oliveira, Ana Maria Caetano de Faria, Luciano dos Santos Aggum Capettini, Jacqueline I. Alvarez-Leite. Dietary gluten worsens hepatic steatosis by increasing inflammation and oxidative stress in ApoE−/− mice fed a high-fat dietFood & Function 2023; 14(7): 3332 doi: 10.1039/D3FO00149K
85
Nooshin Yazdani, Seyed Ebrahim Hossini, Mohammad Amin Edalatmanesh. Anti-inflammatory Effect of Aloe vera Extract on Inflammatory Cytokines of Rats Fed with a High-Fat Diet (HFD)Jundishapur Journal of Natural Pharmaceutical Products 2021; 17(1) doi: 10.5812/jjnpp.114323
86
Angeliki Katsarou, Ioannis I Moustakas, Iryna Pyrina, Panagiotis Lembessis, Michael Koutsilieris, Antonios Chatzigeorgiou. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2020; 26(17): 1993-2011 doi: 10.3748/wjg.v26.i17.1993
87
Laila Naif Al-Harbi, Ghedeir M. Alshammari, Alhanouf Mohammed Al-Dossari, Pandurangan Subash-Babu, Manal Abdulaziz Binobead, Maha H. Alhussain, Sahar Abdulaziz AlSedairy, Doha M. Al-Nouri, Ghalia Shamlan. Beta vulgaris L. (Beetroot) Methanolic Extract Prevents Hepatic Steatosis and Liver Damage in T2DM Rats by Hypoglycemic, Insulin-Sensitizing, Antioxidant Effects, and Upregulation of PPARαBiology 2021; 10(12): 1306 doi: 10.3390/biology10121306
88
Patricia Diez-Echave, Teresa Vezza, Francesca Algieri, Antonio Jesús Ruiz-Malagón, Laura Hidalgo-García, Federico García, Rocío Morón, Manuel Sánchez, Marta Toral, Miguel Romero, Juan Duarte, José Garrido-Mesa, María Elena Rodríguez-Cabezas, Alba Rodríguez-Nogales, Julio Gálvez. The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiomeBiomedicine & Pharmacotherapy 2022; 153: 113445 doi: 10.1016/j.biopha.2022.113445
89
Min Cheol Kim, Jung Gil Park, Byung Ik Jang, Heon Ju Lee, Won Kee Lee. Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver diseaseMedicine 2019; 98(6): e14139 doi: 10.1097/MD.0000000000014139
90
L. E. Tabikhanova, L. P. Osipova, T. V. Churkina, S. S. Kovalev, M. L. Filipenko, E. N. Voronina. Increased Frequencies of ‒174G and ‒572C <i>IL6</i> Alleles in Populations of Indigenous Peoples of Siberia Compared to RussiansМолекулярная биология 2023; 57(2): 350 doi: 10.31857/S0026898423020210
91
Abril Alondra Barrientos-Bonilla, Rasajna Nadella, Paola Belem Pensado-Guevara, Aurora del Carmen Sánchez-García, Laura Mireya Zavala-Flores, Abraham Puga-Olguín, Arnulfo Villanueva-Olivo, Daniel Hernandez-Baltazar. Caspase-3-related apoptosis prevents pathological regeneration in a living liver donor rat modelAdvances in Medical Sciences 2021; 66(1): 176 doi: 10.1016/j.advms.2021.02.003
92
Nan Zhu, Xiaoliang Wang, Huiting Zhu, Yue Zheng. Blood cell parameters and risk of nonalcoholic fatty liver disease: a comprehensive Mendelian randomization studyBMC Medical Genomics 2024; 17(1) doi: 10.1186/s12920-024-01879-7
93
Oytun Erbaş, Hüseyin Serdar Akseki, Volkan Solmaz, Hüseyin Aktuğ, Dilek Taşkıran. Fatty liver‐induced changes in stereotypic behavior in rats and effects of glucagon‐like peptide‐1 analog on stereotypyThe Kaohsiung Journal of Medical Sciences 2014; 30(9): 447 doi: 10.1016/j.kjms.2014.05.007
94
Chia Ju Chang, Shorong-Shii Liou, Thing-Fong Tzeng, I-Min Liu. The ethanol extract of Zingiber zerumbet Smith attenuates non-alcoholic fatty liver disease in hamsters fed on high-fat dietFood and Chemical Toxicology 2014; 65: 33 doi: 10.1016/j.fct.2013.11.048
95
Ik-Rak Jung, Rexford S. Ahima, Sangwon F. Kim. Time-Restricted Feeding Ameliorates Methionine–Choline Deficient Diet-Induced Steatohepatitis in MiceInternational Journal of Molecular Sciences 2024; 25(3): 1390 doi: 10.3390/ijms25031390
96
Dürdane Aksoy, Volkan Solmaz, Dilek Taşkıran, Oytun Erbaş. The association between seizure predisposition and inflammation in a rat model of fatty liver diseaseNeurological Sciences 2014; 35(9): 1441 doi: 10.1007/s10072-014-1778-5
97
Songpei Li, Xiao-Yi Zeng, Xiu Zhou, Hao Wang, Eunjung Jo, Stephen R. Robinson, Aimin Xu, Ji-Ming Ye. Dietary cholesterol induces hepatic inflammation and blunts mitochondrial function in the liver of high-fat-fed miceThe Journal of Nutritional Biochemistry 2016; 27: 96 doi: 10.1016/j.jnutbio.2015.08.021
98
Safa Tahmasebi, Hassan Neishaboori, Davood Jafari, Elham Faghihzadeh, Abdolreza Esmaeilzadeh, Abbas Mirshafiey. The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditionsImmunopharmacology and Immunotoxicology 2021; 43(5): 562 doi: 10.1080/08923973.2021.1954946
99
Savinda Liyanagedera, Robert Patrick Williams, Silvio Veraldi, Valerio Nobili, Jake P. Mann. The pharmacological management of NAFLD in children and adolescentsExpert Review of Clinical Pharmacology 2017; 10(11): 1225 doi: 10.1080/17512433.2017.1365599
100
I. V. Kurbatova, L. V. Topchieva, O. P. Dudanova. Gene TNF Polymorphism -308G>A (rs1800629) and Its Relationship with the Efficiency of Ursodeoxycholic Acid Therapy in Patients with Nonalcoholic StetohepatitisBulletin of Experimental Biology and Medicine 2017; 164(2): 181 doi: 10.1007/s10517-017-3953-1
101
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Human-based systems: Mechanistic NASH modelling just around the corner?Pharmacological Research 2018; 134: 257 doi: 10.1016/j.phrs.2018.06.029
102
Chigusa Kikuchi, Akiko Sakasai-Sakai, Risa Okimura, Hinako Tanaka, Takanobu Takata, Masayoshi Takeuchi, Tamihide Matsunaga. Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem CellsBiological and Pharmaceutical Bulletin 2021; 44(10): 1399 doi: 10.1248/bpb.b21-00520
103
Pallavi Subramanian, Jochen Hampe, Frank Tacke, Triantafyllos Chavakis. Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)International Journal of Molecular Sciences 2022; 23(13): 6996 doi: 10.3390/ijms23136996
104
Karmin O, Connie W.H. Woo, Victoria Sid, Yaw L. Siow. Molecular Nutrition2020; : 323 doi: 10.1016/B978-0-12-811907-5.00028-2
105
Jung-Pyo Yang, Ji-Hun Shin, Seung-Hwan Seo, Sang-Gyun Kim, Sang Lee, Eun-Hee Shin. Effects of Antioxidants in Reducing Accumulation of Fat in HepatocyteInternational Journal of Molecular Sciences 2018; 19(9): 2563 doi: 10.3390/ijms19092563
106
Nathalia Soares da Cruz, Gabriel Pasquarelli-do-Nascimento, Augusto Cézar Polveiro e Oliveira, Kelly Grace Magalhães. Inflammasome-Mediated Cytokines: A Key Connection between Obesity-Associated NASH and Liver Cancer ProgressionBiomedicines 2022; 10(10): 2344 doi: 10.3390/biomedicines10102344
107
Xiang Tao, Haiqing He, Jiangtong Peng, Rui Xu, Jing Fu, Yuting Hu, Li Li, Xiaoyan Yang, Xiuling Feng, Chao Zhang, Lingmin Zhang, Xiyong Yu, Ao Shen, Kai Huang, Qin Fu. Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilastPharmacological Research 2022; 175: 106004 doi: 10.1016/j.phrs.2021.106004
108
Abdo Mahli, Michael Saugspier, Andreas Koch, Judith Sommer, Peter Dietrich, Seren Lee, Reinhard Thasler, Jan Schulze-Luehrmann, Anja Luehrmann, Wolfgang Erwin Thasler, Martina Müller, Anja Bosserhoff, Claus Hellerbrand. ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitisGut 2017; : gutjnl-2016-312485 doi: 10.1136/gutjnl-2016-312485
109
L. V. Topchieva, I. V. Kurbatova, O. P. Dudanova, A. A. Sokolovskaya, A. A. Shipovskaya. IL6R Gene Polymorphic Variant rs2228145(C >A) as a Marker of Genetic Liability to Nonalcoholic Steatohepatitis in the Russian Population of KareliaBulletin of Experimental Biology and Medicine 2018; 165(1): 64 doi: 10.1007/s10517-018-4100-3
110
Feng Tian, Ya Jie Zhang, Yu Li, Ying Xie, Yu Wang. Celecoxib Ameliorates Non-Alcoholic Steatohepatitis in Type 2 Diabetic Rats via Suppression of the Non-Canonical Wnt Signaling Pathway ExpressionPLoS ONE 2014; 9(1): e83819 doi: 10.1371/journal.pone.0083819
111
Элеонора Николаевна Трушина. ABOUT THE MECHANISMS OF THE PROTECTIVE INFLUENCE OF CARNOSINE IN NON-ALCOHOLIC FATTY LIVER DISEASEНаука. Исследования. Практика: сборник избранных статей по материалам Международной научной конференции (Санкт-Петербург, Декабрь 2021) 2022; : 35 doi: 10.37539/SRP300.2021.75.64.005
112
Larisse Longo, Josimar Macedo de Castro, Melina Belén Keingeski, Pabulo Henrique Rampelotto, Dirson João Stein, Gabriel Tayguara Silveira Guerreiro, Valessa Emanoele Gabriel de Souza, Carlos Thadeu Schmidt Cerski, Carolina Uribe-Cruz, Iraci L.S. Torres, Mário Reis Álvares-da-Silva. Nicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet–induced obesity in ratsNutrition 2023; 110: 112019 doi: 10.1016/j.nut.2023.112019
113
Pawel A. Kolodziejski, Natalia Leciejewska, Agata Chmurzynska, Maciej Sassek, Aleksandra Szczepankiewicz, Dawid Szczepankiewicz, Emilian Malek, Mathias Z. Strowski, Zuzanna Checinska-Maciejewska, Krzysztof W. Nowak, Ewa Pruszynska-Oszmalek. 30-Day spexin treatment of mice with diet-induced obesity (DIO) and type 2 diabetes (T2DM) increases insulin sensitivity, improves liver functions and metabolic statusMolecular and Cellular Endocrinology 2021; 536: 111420 doi: 10.1016/j.mce.2021.111420
114
I. V. Kurbatova, L. V. Topchieva, O. P. Dudanova. Caspase 3, 6, 8, and 9 Gene Expression in Peripheral Blood Leukocytes and Plasma Concentrations of IL-6 and TNF-α in Carriers of Different Polymorphic Marker -174G>C Genotypes of IL6 Gene Associated with the Risk of Nonalcoholic SteatohepatitisBulletin of Experimental Biology and Medicine 2017; 162(3): 370 doi: 10.1007/s10517-017-3618-0
115
Peng Song, Junbin Zhang, Yunwei Zhang, Zhiping Shu, Peng Xu, Long He, Chao Yang, Jinxiang Zhang, Hui Wang, Yiqing Li, Qin Li. Hepatic recruitment of CD11b+Ly6C+ inflammatory monocytes promotes hepatic ischemia/reperfusion injuryInternational Journal of Molecular Medicine 2017;  doi: 10.3892/ijmm.2017.3315
116
Mary P. Moore, Rory P. Cunningham, Rachel A. H. Davis, Sarah E. Deemer, Brandon M. Roberts, Eric P. Plaisance, R. Scott Rector. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(4): G564 doi: 10.1152/ajpgi.00259.2020
117
Fu Chen, Yong Zhou, Zhiyuan Wu, Yunze Li, Wenlong Zhou, Yong Wang. Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass SurgeryFrontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.611213
118
Patrice Marques, Vera Francisco, Laura Martínez-Arenas, Ângela Carvalho-Gomes, Elena Domingo, Laura Piqueras, Marina Berenguer, Maria-Jesus Sanz. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2023; 24(3): 2313 doi: 10.3390/ijms24032313
119
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinomaJournal of Cellular Biochemistry 2022; 123(10): 1553 doi: 10.1002/jcb.30252
120
Ilias D. Vachliotis, Ioannis Valsamidis, Stergios A. Polyzos. Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular CarcinomaCancers 2023; 15(21): 5306 doi: 10.3390/cancers15215306
121
H M Kim, B R Lee, E S Lee, M H Kwon, J H Huh, B-E Kwon, E-K Park, S-Y Chang, M-N Kweon, P-H Kim, H-J Ko, C H Chung. iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent mannerInternational Journal of Obesity 2018; 42(2): 270 doi: 10.1038/ijo.2017.200
122
Mayada Metwally, Mohammed Eslam, Jacob George. Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision MakingCurrent Hepatology Reports 2017; 16(4): 335 doi: 10.1007/s11901-017-0372-8
123
Dong Ji, Gregory Cheng, George Lau. Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues”Journal of Hepatology 2021; 74(2): 484 doi: 10.1016/j.jhep.2020.10.020
124
Mojtaba Rashidi, Reza Afarin, Maryam Kouchak, Benyamin Kabizadeh, Masoumeh Shamsi, Mahdi Hatami. Resveratrol and Saroglitazar: A Promising Combination for Targeting TGF-β/Smad3 Signaling and Attenuating Inflammatory Response in Nonalcoholic Steatohepatitis in RatsHepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-138237
125
David J. Orlicky, Andrew E. Libby, Elise S. Bales, Rachel H. McMahan, Jenifer Monks, Francisco G. La Rosa, James L. McManaman. Perilipin‐2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra‐hepatocyte actionsThe Journal of Physiology 2019; 597(6): 1565 doi: 10.1113/JP277140
126
I V Kurbatova, L V Topchieva, O P Dudanova, A A Shipovskaya. Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitisTerapevticheskii arkhiv 2019; 91(4): 21 doi: 10.26442/00403660.2019.04.000057
127
Eva Peterová, Lucie Podmolíková, Martina Řezáčová, Alena Mrkvicová. Fibroblast Growth Factor-1 Suppresses TGF-β-Mediated Myofibroblastic Differentiation of Rat Hepatic Stellate CellsActa Medica (Hradec Kralove, Czech Republic) 2016; 59(4): 124 doi: 10.14712/18059694.2017.39
128
William K. K. Wu, Lin Zhang, Matthew T. V. Chan. Obesity, Fatty Liver and Liver CancerAdvances in Experimental Medicine and Biology 2018; 1061: 127 doi: 10.1007/978-981-10-8684-7_10
129
A. MORAVCOVÁ, Z. ČERVINKOVÁ, O. KUČERA, V. MEZERA, D. RYCHTRMOC, H. LOTKOVÁ. The Effect of Oleic and Palmitic Acid on Induction of Steatosis and Cytotoxicity on Rat Hepatocytes in Primary CulturePhysiological Research 2015; : S627 doi: 10.33549/physiolres.933224
130
Vettickattuparambil George Giby, Thekkuttuparambil Ananthanarayanan Ajith. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver diseaseWorld Journal of Hepatology 2014; 6(8): 570-579 doi: 10.4254/wjh.v6.i8.570
131
Dong Ji, Mingjie Zhang, Enqiang Qin, Lunqing Zhang, Jing Xu, Yudong Wang, Gregory Cheng, Feng Wang, George Lau. Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19Metabolism 2021; 115: 154437 doi: 10.1016/j.metabol.2020.154437
132
Charles I. V. Drummer, Fatma Saaoud, Yu Sun, Diana Atar, Keman Xu, Yifan Lu, Ying Shao, Candice Johnson, Lu Liu, Huimin Shen, Nirag C. Jhala, Xiaohua Jiang, Hong Wang, Xiaofeng Yang, Baohui Xu. Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLDJournal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/3928323
133
Jun-Qi Shi, Wen-Xia Shen, Xiang-Zhi Wang, Ke Huang, Chao-Chun Zou. Relationship between immune parameters and non-alcoholic fatty liver disease in obese childrenIndian Pediatrics 2017; 54(10): 825 doi: 10.1007/s13312-017-1143-x
134
Natalie Stiglund, Hannes Hagström, Per Stål, Martin Cornillet, Niklas K. Björkström. Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biologyFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1186097
135
Rongrong Zhou, Xuegong Fan, Bernd Schnabl. Role of the intestinal microbiome in liver fibrosis development and new treatment strategiesTranslational Research 2019; 209: 22 doi: 10.1016/j.trsl.2019.02.005
136
Mei-Ling Su, Yu He, Qi-Sen Li, Bang-Hao Zhu. Efficacy of Acetylshikonin in Preventing Obesity and Hepatic Steatosis in db/db MiceMolecules 2016; 21(8): 976 doi: 10.3390/molecules21080976
137
Jharna Puppala, Siva Prasad Siddapuram, Jyothy Akka, Anjana Munshi. Genetics of Nonalcoholic Fatty Liver Disease: An OverviewJournal of Genetics and Genomics 2013; 40(1): 15 doi: 10.1016/j.jgg.2012.12.001
138
Shari S. Rogal, Klaus Bielefeldt, Ajay D. Wasan, Eva Szigethy, Francis Lotrich, Andrea F. DiMartini. Fibromyalgia Symptoms and CirrhosisDigestive Diseases and Sciences 2015; 60(5): 1482 doi: 10.1007/s10620-014-3453-3
139
Shoumo Bhattacharya, Akane Kawamura. Inflammatory Disorders, Part AAdvances in Protein Chemistry and Structural Biology 2020; 119: 1 doi: 10.1016/bs.apcsb.2019.09.003
140
Ayokanmi Ore, Oluseyi Adeboye Akinloye, Abideen Idowu Adeogun, Regina Ngozi Ugbaja, Eric Morifi, Maya Makatini, Refilwe Moepya, Thapelo Mbhele. Buchholzia coriacea seed (wonderful kolanut) alleviates insulin resistance, steatosis, inflammation and oxidative stress in high fat diet model of fatty liver disease Journal of Food Biochemistry 2022; 46(3) doi: 10.1111/jfbc.13836
141
Ding‐You Li, Min Yang, Sarah Edwards, Shui‐Qing Ye. Nonalcoholic Fatty Liver DiseaseJournal of Parenteral and Enteral Nutrition 2013; 37(6): 787 doi: 10.1177/0148607113481623
142
Yoshihisa Takahashi, Keiichiro Sugimoto, Yurie Soejima, Arisa Kumagai, Tatsuki Koeda, Aiko Shojo, Kazuya Nakagawa, Naoki Harada, Ryoichi Yamaji, Hiroshi Inui, Toshikazu Yamanouchi, Toshio Fukusato. Inhibitory Effects of Eucalyptus and Banaba Leaf Extracts on Nonalcoholic Steatohepatitis Induced by a High-Fructose/High-Glucose Diet in RatsBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/296207
143
Ji-Su Ahn, Ji Won Yang, Su-Jeong Oh, Ye Young Shin, Min-Jung Kang, Hae Ryoun Park, Yoojin Seo, Hyung-Sik Kim. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathwayBMB Reports 2021; 54(6): 323 doi: 10.5483/BMBRep.2021.54.6.050
144
Deepika Kumari, Jyoti Gautam, Vipin Sharma, Sonu Kumar Gupta, Soumalya Sarkar, Pradipta Jana, Vikas Singhal, Prabhakar Babele, Parul Kamboj, Sneh Bajpai, Ruchi Tandon, Yashwant Kumar, Madhu Dikshit. Effect of herbal extracts and Saroglitazar on high-fat diet-induced obesity, insulin resistance, dyslipidemia, and hepatic lipidome in C57BL/6J miceHeliyon 2023; 9(11): e22051 doi: 10.1016/j.heliyon.2023.e22051
145
Atul Goyale, Anjly Jain, Colette Smith, Margarita Papatheodoridi, Marta Guerrero Misas, Davide Roccarina, Laura Iogna Prat, Dimitri P. Mikhailidis, Devaki Nair, Emmanuel Tsochatzis, Pavel Strnad. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot studyPLOS ONE 2021; 16(11): e0260313 doi: 10.1371/journal.pone.0260313
146
M. Elaine Husni. Comorbidities in Psoriatic ArthritisRheumatic Disease Clinics of North America 2015; 41(4): 677 doi: 10.1016/j.rdc.2015.07.008
147
Francislaine AR Lívero, Alexandra Acco. Molecular basis of alcoholic fatty liver disease: From incidence to treatmentHepatology Research 2016; 46(1): 111 doi: 10.1111/hepr.12594
148
Francesco Bellanti, Gianluigi Vendemiale. Coronavirus disease 2019 and non-alcoholic fatty liver diseaseWorld Journal of Hepatology 2021; 13(9): 969-978 doi: 10.4254/wjh.v13.i9.969
149
Chuxin Huang, Jiali Qian, Ying Liu, Li Zhang, Yehong Yang. Empagliflozin attenuates liver fibrosis in high‐fat diet/streptozotocin‐induced mice by modulating gut microbiotaClinical and Experimental Pharmacology and Physiology 2024; 51(3) doi: 10.1111/1440-1681.13842
150
Yeon-Hui Jeong, Haeng Hur, Eun-Joo Jeon, Su-Jin Park, Jin Hwang, Ae Lee, Kyong Lee, Mi Sung. Honokiol Improves Liver Steatosis in Ovariectomized MiceMolecules 2018; 23(1): 194 doi: 10.3390/molecules23010194
151
Martha D. Gay, Anita Safronenka, Hong Cao, Felice H. Liu, Zoe X. Malchiodi, Robin D. Tucker, Alexander Kroemer, Narayan Shivapurkar, Jill P. Smith. Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular CancerCancer Prevention Research 2021; 14(1): 17 doi: 10.1158/1940-6207.CAPR-20-0220
152
Kangkang Yin, Xiao Zhou, Wei Jiang, Linlin Wang, Ziwei Dai, Biao Tang, Gaetano Isola. Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver DiseaseDisease Markers 2021; 2021: 1 doi: 10.1155/2021/9963534
153
Pratibha Gaur, Marcin Cebula, Mathias Riehn, Upneet Hillebrand, Hansjörg Hauser, Dagmar Wirth. Diet induced obesity has an influence on intrahepatic T cell responsesMetabolism 2017; 69: 171 doi: 10.1016/j.metabol.2017.01.022
154
Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour. Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver DiseaseChinese Journal of Integrative Medicine 2022; 28(6): 531 doi: 10.1007/s11655-022-3307-3
155
Yufang Ding, Karin Yanagi, Fang Yang, Evelyn Callaway, Clint Cheng, Martha E Hensel, Rani Menon, Robert C Alaniz, Kyongbum Lee, Arul Jayaraman. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in miceeLife 2024; 12 doi: 10.7554/eLife.87458.3
156
Aleksander Danikiewicz, Bartosz Hudzik, Justyna Nowak, Joanna Kowalska, Iwona Zieleń-Zynek, Janusz Szkodzinski, Han Naung Tun, Barbara Zubelewicz-Szkodzinska. Serum Gamma Glutamyltransferase Is Associated with 25-Hydroxyvitamin D Status in Elderly Patients with Stable Coronary Artery DiseaseInternational Journal of Environmental Research and Public Health 2020; 17(23): 8980 doi: 10.3390/ijerph17238980
157
Masoumeh Norouzpour, Sayed Mohammad Marandi, Mohsen Ghanbarzadeh, Abbasali Zare Maivan. Response of Inflammatory Biomarkers to 10 Weeks of Aerobic Resistance Training in Inactive Postmenopausal Women with Non-alcoholic Fatty LiverJundishapur Journal of Chronic Disease Care 2021; 10(3) doi: 10.5812/jjcdc.114163
158
Hironori Kitade, Guanliang Chen, Yinhua Ni, Tsuguhito Ota. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New TreatmentsNutrients 2017; 9(4): 387 doi: 10.3390/nu9040387
159
Maisa Mahmoud Ali Kamkar, Rasheed Ahmad, Osama Alsmadi, Kazem Behbehani. Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-reviewJournal of Diabetes & Metabolic Disorders 2014; 13(1) doi: 10.1186/2251-6581-13-57
160
Li Qin, Junru Wu, Xuejing Sun, Xuewei Huang, Wei Huang, Chunyan Weng, Jingjing Cai. The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular diseaseFrontiers in Cardiovascular Medicine 2023; 10 doi: 10.3389/fcvm.2023.1119005
161
Sen Zhang, Wu-Yi Sun, Jing-Jing Wu, Wei Wei. TGF-β signaling pathway as a pharmacological target in liver diseasesPharmacological Research 2014; 85: 15 doi: 10.1016/j.phrs.2014.05.005
162
Zhisheng Her, Joel Heng Loong Tan, Yee-Siang Lim, Sue Yee Tan, Xue Ying Chan, Wilson Wei Sheng Tan, Min Liu, Kylie Su Mei Yong, Fritz Lai, Erica Ceccarello, Zhiqiang Zheng, Yong Fan, Kenneth Tou En Chang, Lei Sun, Shih Chieh Chang, Chih-Liang Chin, Guan Huei Lee, Yock Young Dan, Yun-Shen Chan, Seng Gee Lim, Jerry Kok Yen Chan, K. George Chandy, Qingfeng Chen. CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized MiceFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.580968
163
Nada Pejnovic, Ilija Jeftic, Nemanja Jovicic, Nebojsa Arsenijevic, Miodrag L Lukic. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitisWorld Journal of Gastroenterology 2016; 22(44): 9706-9717 doi: 10.3748/wjg.v22.i44.9706
164
Pratima Dibba, Andrew A Li, George Cholankeril, Muhammad Ali Khan, Donghee Kim, Aijaz Ahmed. Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A CommentaryNutrition and Metabolic Insights 2019; 12: 117863881984748 doi: 10.1177/1178638819847480
165
Amandeep Singh Arora, Saima Zafar, Umair Latif, Franc Llorens, Sabine Mihm, Prateek Kumar, Waqas Tahir, Katrin Thüne, Mohsin Shafiq, Matthias Schmitz, Inga Zerr. The role of cellular prion protein in lipid metabolism in the liverPrion 2020; 14(1): 95 doi: 10.1080/19336896.2020.1729074
166
Akshatha N. Srinivas, Diwakar Suresh, Prasanna K. Santhekadur, Deepak Suvarna, Divya P. Kumar. Extracellular Vesicles as Inflammatory Drivers in NAFLDFrontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.627424
167
Alexander Wree, Matthew D. McGeough, Maria Eugenia Inzaugarat, Akiko Eguchi, Susanne Schuster, Casey D. Johnson, Carla A. Peña, Lukas J. Geisler, Bettina G. Papouchado, Hal M. Hoffman, Ariel E. Feldstein. NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL‐17 and TNF in miceHepatology 2018; 67(2): 736 doi: 10.1002/hep.29523
168
Guy Bower, Thanos Athanasiou, Alberto M. Isla, Leanne Harling, Jia V. Li, Elaine Holmes, Evangelos Efthimiou, Ara Darzi, Hutan Ashrafian. Bariatric surgery and nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2015; 27(7): 755 doi: 10.1097/MEG.0000000000000375
169
Aldo Lagomarsino. Liver regeneration in nonalcoholic fatty liver diseaseMedwave 2012; 12(11): e5559 doi: 10.5867/medwave.2012.11.5559
170
Kyu-Hyouck Kyoung, Sung-Gyu Lee, Shin Hwang, Ki-Hun Kim, Suk-Kyung Hong. Liver Steatosis in Brain-Dead Donors: Progression Pattern and Affecting FactorsTransplantation Proceedings 2020; 52(5): 1318 doi: 10.1016/j.transproceed.2020.02.161
171
Yuan Yao, Yunfeng Shen. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic targetOpen Life Sciences 2023; 18(1) doi: 10.1515/biol-2022-0699
172
Soo Lim, Tae Jung Oh, Kwang Kon Koh. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disordersInternational Journal of Cardiology 2015; 201: 408 doi: 10.1016/j.ijcard.2015.08.107
173
Yoshihisa Takahashi, Yurie Soejima, Arisa Kumagai, Masato Watanabe, Hiroshi Uozaki, Toshio Fukusato, Kalpana Ghoshal. Inhibitory Effects of Japanese Herbal Medicines Sho-saiko-to and Juzen-taiho-to on Nonalcoholic Steatohepatitis in MicePLoS ONE 2014; 9(1): e87279 doi: 10.1371/journal.pone.0087279
174
Chia-Chu Chang, Chia-Lin Wu, Wei-Wen Su, Kai-Lun Shih, Der-Cherng Tarng, Chen-Te Chou, Ting-Yu Chen, Chew-Teng Kor, Hung-Ming Wu. Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver diseaseScientific Reports 2015; 5(1) doi: 10.1038/srep10096
175
Vishal Patel, Amit Joharapurkar, Samadhan Kshirsagar, Brijesh Sutariya, Maulik Patel, Dheerendra Pandey, Hiren Patel, Ramchandra Ranvir, Shekhar Kadam, Dipam Patel, Rajesh Bahekar, Mukul Jain. Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic conditionChemico-Biological Interactions 2018; 282: 13 doi: 10.1016/j.cbi.2018.01.004
176
Douglas M Oswald, Mark B Jones, Brian A Cobb. Modulation of hepatocyte sialylation drives spontaneous fatty liver disease and inflammationGlycobiology 2020; 30(5): 346 doi: 10.1093/glycob/cwz096
177
Helda Tutunchi, Farideh Zolrahim, Mahlagha Nikbaf-Shandiz, Fatemeh Naeini, Alireza Ostadrahimi, Sina Naghshi, Reza Salek, Farzad Najafipour. Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trialFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1144550
178
Kerstin Knoop, Nathalie Schwenk, Patrick Dolp, Michael J. Willhauck, Christoph Zischek, Christian Zach, Markus Hacker, Burkhard Göke, Ernst Wagner, Peter J. Nelson, Christine Spitzweg. Stromal Targeting of Sodium Iodide Symporter Using Mesenchymal Stem Cells Allows Enhanced Imaging and Therapy of Hepatocellular CarcinomaHuman Gene Therapy 2013; 24(3): 306 doi: 10.1089/hum.2012.104
179
Yaping Wang, Xiaobo Li, Shunlin Ren. Cholesterol Metabolites 25-Hydroxycholesterol and 25-Hydroxycholesterol 3-Sulfate Are Potent Paired Regulators: From Discovery to Clinical UsageMetabolites 2020; 11(1): 9 doi: 10.3390/metabo11010009
180
Sara Arefhosseini, Helda Tutunchi, Solmaz Nomi-Golzar, Soltanali Mahboob, Zohre Pouretedal, Mehrangiz Ebrahimi-Mameghani. The effect of hydroxy citric acid supplementation with calorie-restricted diet on metabolic, atherogenic and inflammatory biomarkers in women with non-alcoholic fatty liver disease: a randomized controlled clinical trialFood & Function 2022; 13(9): 5124 doi: 10.1039/D1FO03685H
181
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
182
Ki Wung Chung, Ye Eun Cho, Seung-Jin Kim, Seonghwan Hwang. Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitisArchives of Pharmacal Research 2022; 45(4): 229 doi: 10.1007/s12272-022-01379-1
183
Ursa Kovac, Damjana Rozman. Encyclopedia of Life Sciences2015; : 1 doi: 10.1002/9780470015902.a0025335
184
Klaudia Berk, Wiktor Bzdega, Karolina Konstantynowicz-Nowicka, Tomasz Charytoniuk, Hubert Zywno, Adrian Chabowski. Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease TreatmentJournal of Clinical Medicine 2021; 10(3): 393 doi: 10.3390/jcm10030393
185
Nikos Stratakis, Lucy Golden‐Mason, Katerina Margetaki, Yinqi Zhao, Damaskini Valvi, Erika Garcia, Léa Maitre, Sandra Andrusaityte, Xavier Basagana, Eva Borràs, Mariona Bustamante, Maribel Casas, Serena Fossati, Regina Grazuleviciene, Line Småstuen Haug, Barbara Heude, Rosemary R.C. McEachan, Helle Margrete Meltzer, Eleni Papadopoulou, Theano Roumeliotaki, Oliver Robinson, Eduard Sabidó, Jose Urquiza, Marina Vafeiadi, Nerea Varo, John Wright, Miriam B. Vos, Howard Hu, Martine Vrijheid, Kiros T. Berhane, David V. Conti, Rob McConnell, Hugo R. Rosen, Lida Chatzi. In Utero Exposure to Mercury Is Associated With Increased Susceptibility to Liver Injury and Inflammation in ChildhoodHepatology 2021; 74(3): 1546 doi: 10.1002/hep.31809
186
Rasoul Akbari, Tahereh Behdarvand, Reza Afarin, Hamid Yaghooti, Mohammad Taha Jalali, Narges Mohammadtaghvaei. Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitisBMC Pharmacology and Toxicology 2021; 22(1) doi: 10.1186/s40360-021-00524-8
187
Adil Mardinoglu, Hao Wu, Elias Bjornson, Cheng Zhang, Antti Hakkarainen, Sari M. Räsänen, Sunjae Lee, Rosellina M. Mancina, Mattias Bergentall, Kirsi H. Pietiläinen, Sanni Söderlund, Niina Matikainen, Marcus Ståhlman, Per-Olof Bergh, Martin Adiels, Brian D. Piening, Marit Granér, Nina Lundbom, Kevin J. Williams, Stefano Romeo, Jens Nielsen, Michael Snyder, Mathias Uhlén, Göran Bergström, Rosie Perkins, Hanns-Ulrich Marschall, Fredrik Bäckhed, Marja-Riitta Taskinen, Jan Borén. An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in HumansCell Metabolism 2018; 27(3): 559 doi: 10.1016/j.cmet.2018.01.005
188
Oliver Glass, Ricardo Henao, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Wing‐Kin Syn, Cynthia A. Moylan, Robert Streilein, Russell Hall, Anna Mae Diehl, Manal F. Abdelmalek. Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseHepatology Communications 2018; 2(11): 1344 doi: 10.1002/hep4.1237
189
Carlotta Hoffmann, Philipp A. Gerber, Claudia Cavelti-Weder, Louisa Licht, Reham Kotb, Rania Al Dweik, Michele Cherfane, Stefan R. Bornstein, Nikolaos Perakakis. Liver, NAFLD and COVID-19Hormone and Metabolic Research 2022; 54(08): 522 doi: 10.1055/a-1834-9008
190
Michael J. Duryee, Monte S. Willis, Courtney S. Schaffert, Roger D. Reidelberger, Anand Dusad, Daniel R. Anderson, Lynell W. Klassen, Geoffrey M. Thiele. Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 306(3): G208 doi: 10.1152/ajpgi.00124.2013
191
Zhenwei Gong, Emir Tas, Shoshana Yakar, Radhika Muzumdar. Hepatic lipid metabolism and non-alcoholic fatty liver disease in agingMolecular and Cellular Endocrinology 2017; 455: 115 doi: 10.1016/j.mce.2016.12.022
192
Fanping Meng, Yao Lin, Min Yang, Minyan Li, Gangyi Yang, Po Hao, Ling Li. JAZF1 Inhibits Adipose Tissue Macrophages and Adipose Tissue Inflammation in Diet-Induced Diabetic MiceBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/4507659
193
Tomasz Kostrzewski, Terri Cornforth, Sophie A Snow, Larissa Ouro-Gnao, Cliff Rowe, Emma M Large, David J Hughes. Three-dimensional perfused human <i>in vitro</i> model of non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2017; 23(2): 204-215 doi: 10.3748/wjg.v23.i2.204
194
Natalia de las Heras, María Valero-Muñoz, Beatriz Martín-Fernández, Sandra Ballesteros, Antonio López-Farré, Baltasar Ruiz-Roso, Vicente Lahera. Molecular factors involved in the hypolipidemic- and insulin-sensitizing effects of a ginger (Zingiber officinale Roscoe) extract in rats fed a high-fat dietApplied Physiology, Nutrition, and Metabolism 2017; 42(2): 209 doi: 10.1139/apnm-2016-0374
195
Abdullah S. Shatoor, Suliman Al Humayed, Hussain M. Almohiy. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2Journal of Physiology and Biochemistry 2022; 78(1): 151 doi: 10.1007/s13105-021-00850-9
196
Martin Kächele, Stefan Wolff, Wolfgang Kratzer, Mark Haenle, Jörg Homann, Gerlinde Trischler, Wolfgang Koenig, Armin Imhof. Presence of Fatty Liver and the Relationship between Alcohol Consumption and Markers of InflammationMediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/278785
197
Nurgul Toktogulova, Rustam Tukhvatshin, Elmira Mainazarova. Dynamics of Pro- and Anti-inflammatory Cytokines in Experimental Animals with Non-alcoholic Fatty Liver Disease Under Conditions of Hypobaric HypoxiaOpen Access Macedonian Journal of Medical Sciences 2021; 9(A): 822 doi: 10.3889/oamjms.2021.7016
198
Min Cao, Bin Cui. Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analysesCardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02222-1
199
Jonathan Gotfried, Timna Naftali, Ron Schey. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic DiseaseGastroenterology 2020; 159(1): 62 doi: 10.1053/j.gastro.2020.03.087
200
Rory P. Cunningham, Mary P. Moore, Angelique N. Moore, James C. Healy, Michael D. Roberts, R. Scott Rector, Jeffrey S. Martin. Curcumin supplementation mitigates NASH development and progression in female Wistar ratsPhysiological Reports 2018; 6(14): e13789 doi: 10.14814/phy2.13789
201
Xing Wang, Dong-Mei Zhang, Ting-Ting Gu, Xiao-Qin Ding, Chen-Yu Fan, Qin Zhu, Yun-Wei Shi, Ye Hong, Ling-Dong Kong. Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathwayBiochemical Pharmacology 2013; 86(12): 1791 doi: 10.1016/j.bcp.2013.10.005
202
Alfonso Pastor-Clerigues, Ezequiel Marti-Bonmati, Javier Milara, Patricia Almudever, Julio Cortijo, Partha Mukhopadhyay. Anti-Inflammatory and Anti-Fibrotic Profile of Fish Oil Emulsions Used in Parenteral Nutrition-Associated Liver DiseasePLoS ONE 2014; 9(12): e115404 doi: 10.1371/journal.pone.0115404
203
Holger Cynis, Astrid Kehlen, Monique Haegele, Torsten Hoffmann, Ulrich Heiser, Masato Fujii, Yuichiro Shibazaki, Hiroyuki Yoneyama, Stephan Schilling, Hans‐Ulrich Demuth. Inhibition of Glutaminyl Cyclases alleviates CCL2‐mediated inflammation of non‐alcoholic fatty liver disease in miceInternational Journal of Experimental Pathology 2013; 94(3): 217 doi: 10.1111/iep.12020
204
Sheng Cao, Mengfei Liu, Tejasav S. Sehrawat, Vijay H. Shah. Regulation and functional roles of chemokines in liver diseasesNature Reviews Gastroenterology & Hepatology 2021; 18(9): 630 doi: 10.1038/s41575-021-00444-2
205
Haiyan Chen, Siqi Dai, Yimin Fang, Liubo Chen, Kai Jiang, Qichun Wei, Kefeng Ding. Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis PatientsFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.631943
206
Xiaolin Liu, Yongfeng Wang, Yanan Ming, Yanyan Song, Jingyi Zhang, Xiaoyu Chen, Minde Zeng, Yimin Mao, Hervé Guillou. S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic SteatohepatitisPLOS ONE 2015; 10(5): e0127352 doi: 10.1371/journal.pone.0127352
207
Yufang Ding, Karin Yanagi, Fang Yang, Evelyn Callaway, Clint Cheng, Martha E Hensel, Rani Menon, Robert C Alaniz, Kyongbum Lee, Arul Jayaraman. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in miceeLife 2024; 12 doi: 10.7554/eLife.87458
208
Vishnubhotla Venkata Ravi Kanth, Mitnala Sasikala, Mithun Sharma, Padaki Nagaraja Rao, Duvvuru Nageshwar Reddy. Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to managementWorld Journal of Hepatology 2016; 8(20): 827-837 doi: 10.4254/wjh.v8.i20.827
209
Giuseppina Palladini, Andrea Ferrigno, Laura Giuseppina Di Pasqua, Clarissa Berardo, Vittoria Rizzo, Stefano Perlini, Mariapia Vairetti, Chen Ling. Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver diseasePLOS ONE 2020; 15(12): e0243179 doi: 10.1371/journal.pone.0243179
210
Ling Li, Minjie Xu, Chao He, Hui Wang, Qinglian Hu. Polystyrene nanoplastics potentiate the development of hepatic fibrosis in high fat diet fed miceEnvironmental Toxicology 2022; 37(2): 362 doi: 10.1002/tox.23404
211
Sook In Chung, Hyuk Moon, Hye-Lim Ju, Kyung Joo Cho, Do Young Kim, Kwang-Hyub Han, Jung Woo Eun, Suk Woo Nam, Silvia Ribback, Frank Dombrowski, Diego F. Calvisi, Simon Weonsang Ro. Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse modelJournal of Hepatology 2016; 64(3): 618 doi: 10.1016/j.jhep.2015.10.007
212
Ryusei Uchio, Shinji Murosaki, Hiroshi Ichikawa. Hot water extract of turmeric (Curcuma longa) prevents non-alcoholic steatohepatitis in mice by inhibiting hepatic oxidative stress and inflammationJournal of Nutritional Science 2018; 7 doi: 10.1017/jns.2018.27
213
Haeng Hur, Yeon-Hui Jeong, Sang Lee, Mi Sung. Quercitrin Ameliorates Hyperlipidemia and Hepatic Steatosis in Ovariectomized MiceLife 2020; 10(10): 243 doi: 10.3390/life10100243
214
Jiro H. Situmorang, Ching-Hui Loh, Chih -Yang Huang. Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022)2023; : 75 doi: 10.2991/978-94-6463-112-8_8
215
Michael N. VanSaun, Alisha M. Mendonsa, D. Lee Gorden, Gianluigi Giannelli. Hepatocellular Proliferation Correlates with Inflammatory Cell and Cytokine Changes in a Murine Model of Nonalchoholic Fatty Liver DiseasePLoS ONE 2013; 8(9): e73054 doi: 10.1371/journal.pone.0073054
216
Stanislav Kotlyarov, Aleksei Bulgakov. Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary DiseaseCells 2021; 10(11): 2978 doi: 10.3390/cells10112978
217
Sang Jun Yoon, Jeong Seok Yu, Byeong Hyun Min, Haripriya Gupta, Sung-Min Won, Hee Jin Park, Sang Hak Han, Byung-Yong Kim, Kyung Hwan Kim, Byoung Kook Kim, Hyun Chae Joung, Tae-Sik Park, Young Lim Ham, Do Yup Lee, Ki Tae Suk. Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axisFrontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1129904
218
Ahmed M. El-Baz, Amira M. El-Ganiny, Doaa Hellal, Hala M. Anwer, Hend A. Abd El-Aziz, Ibrahim E. Tharwat, Mohamed A. El-Adawy, Shehab El-Din M. Helal, Menna Tallah A. Mohamed, Tassnim M. Azb, Hanya M. Elshafaey, AbdulRahman A. Shalata, Sahar M. Elmeligi, Noran H. Abdelbary, Attalla F. El-kott, Fatimah A. Al-Saeed, Eman T. Salem, Mohamed M. Adel El-Sokkary, Ahmed Shata, Ahmed A. Shabaan. Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiotaAMB Express 2023; 13(1) doi: 10.1186/s13568-023-01561-8
219
Ahmed A. Sedik, Rania Elgohary, Eman Khalifa, Wagdy K. B. Khalil, Heba I. Shafey, Mohamed B. Shalaby, Mona S. O. Gouida, Yasmin M. Tag. Lauric acid attenuates hepato-metabolic complications and molecular alterations in high-fat diet-induced nonalcoholic fatty liver disease in ratsToxicology Mechanisms and Methods 2024; 34(4): 454 doi: 10.1080/15376516.2023.2301344
220
Amrit Baral, Jingxin Liu, Sandra Garcia-Davis, Bria-Necole A. Diggs, Lizelh Ayala, Anurag Aka, Yash S. Agrawal, Sarah E. Messiah, Denise C. Vidot. Prevalence of Metabolic Syndrome among Emerging Adult Cannabis Users by Race/Ethnicity: Analysis of the 2009-2018 National Health and Nutrition Examination SurveysAmerican Journal of Medicine Open 2024; : 100069 doi: 10.1016/j.ajmo.2024.100069
221
Lu-Min Shih, Hsiang-Yu Tang, Ke-Shiuan Lynn, Cheng-Yu Huang, Hung-Yao Ho, Mei-Ling Cheng. Stable Isotope-Labeled Lipidomics to Unravel the Heterogeneous Development LipotoxicityMolecules 2018; 23(11): 2862 doi: 10.3390/molecules23112862
222
Z. A. Shafigullina, I. G. Danilova, S. Yu. Medvedeva, V. A. Chereshnev, M. T. Abidov. SINUSOIDAL CELLS AND CYTOKINE RESPONSE IN THE TETRACHLOROMETHANE-INDUCED HEPATOTOXICITY AND AN APPROACH TO ITS CORRECTIONMedical Immunology (Russia) 2019; 21(5): 929 doi: 10.15789/1563-0625-2019-5-929-936
223
Ludovico Abenavoli, Emidio Scarpellini, Samir Rouabhia, Clara Balsano, Francesco Luzza. Probiotics in non-alcoholic fatty liver disease: which and whenAnnals of Hepatology 2013; 12(3): 357 doi: 10.1016/S1665-2681(19)30997-4
224
Howard C. Masuoka, Naga Chalasani. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsAnnals of the New York Academy of Sciences 2013; 1281(1): 106 doi: 10.1111/nyas.12016
225
I V Kurbatova, O P Dudanova. Features of a necrotic and inflammatory process in different forms of nonalcoholic fatty liver diseaseTerapevticheskii arkhiv 2017; 89(2): 52 doi: 10.17116/terarkh201789252-58
226
Karina Colonetti, Filippo Pinto e Vairo, Marina Siebert, Tatiéle Nalin, Soraia Poloni, Luiz Fernando Wurdig Roesch, Carolina Fischinger Moura de Souza, Franciele Cabral Pinheiro, Ida Vanessa Doederlein Schwartz. Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects?Cytokine 2023; 162: 156088 doi: 10.1016/j.cyto.2022.156088
227
Masaya Kozono, Hirofumi Uto, Rie Ibusuki, Shiho Arima, Kohei Oda, Hiroki Taguchi, Fumisato Sasaki, Yuichiro Nasu, Shinichi Hashimoto, Hitoshi Setoyama, Shuji Kanmura, Masatsugu Numata, Hirohito Tsubouchi, Akio Ido. Antihypertensive therapy improves insulin resistance and serum levels of interleukin-6 and −10 in spontaneously hypertensive rats with steatohepatitisMolecular Medicine Reports 2016; 14(6): 5385 doi: 10.3892/mmr.2016.5875
228
Shengjie Yang, Renze Peng, Leiming Zhou. The impact of hepatic steatosis on outcomes of colorectal cancer patients with liver metastases: A systematic review and meta-analysisFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.938718
229
María Rubio-Murillo, Alejandro Rodríguez-Martínez. NAFLD and NASH2020; : 69 doi: 10.1007/978-3-030-37173-9_5
230
Naoki Takatani, Yuka Kono, Fumiaki Beppu, Yuko Okamatsu-Ogura, Yumiko Yamano, Kazuo Miyashita, Masashi Hosokawa. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model miceBiochemical and Biophysical Research Communications 2020; 528(2): 305 doi: 10.1016/j.bbrc.2020.05.050
231
Snigdha Jyoti Das, Sangit Dutta, Diptika Tiwari, Tarun Kr Basumatary, Natasha Kashyap, Manash Pratim Kalita, Sujoy Bose, Purabi Deka Bose. Prognostic value of myeloid differentiation primary response protein 88 in type II diabetes mellitus in non-obese NAFLD: A case-control study from AssamHuman Gene 2024; 39: 201246 doi: 10.1016/j.humgen.2023.201246
232
Kejia Liu, Xu Yang, Guihong Zhang, Zheng Xiang. Therapeutic Effect and Mechanism Prediction of Fuzi-Gancao Herb Couple on Non-alcoholic Fatty Liver Disease (NAFLD) based on Network Pharmacology and Molecular DockingCombinatorial Chemistry & High Throughput Screening 2024; 27(5): 773 doi: 10.2174/1386207326666230614102412
233
Ramiar K. Kheder, James Hobkirk, Cordula M. Stover. In vitro Modulation of the LPS-Induced Proinflammatory Profile of Hepatocytes and Macrophages- Approaches for Intervention in Obesity?Frontiers in Cell and Developmental Biology 2016; 4 doi: 10.3389/fcell.2016.00061
234
Jarkko Soronen, Hannele Yki-Järvinen, You Zhou, Sanja Sädevirta, Antti-Pekka Sarin, Marja Leivonen, Ksenia Sevastianova, Julia Perttilä, Pirkka-Pekka Laurila, Alexander Sigruener, Gerd Schmitz, Vesa M. Olkkonen. Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver diseasePhysiological Reports 2016; 4(1): e12661 doi: 10.14814/phy2.12661
235
Samantha Teng, Lipi Chakravorty, Naomi Fleury, Shelley Gorman. Regular exposure to non-burning ultraviolet radiation reduces signs of non-alcoholic fatty liver disease in mature adult mice fed a high fat diet: results of a pilot studyBMC Research Notes 2019; 12(1) doi: 10.1186/s13104-019-4112-8
236
Elisa Alchera, Simona Rolla, Chiara Imarisio, Valentina Bardina, Guido Valente, Francesco Novelli, Rita Carini. Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicityTranslational Research 2017; 182: 75 doi: 10.1016/j.trsl.2016.11.009
237
Liang Xu, Hironori Kitade, Yinhua Ni, Tsuguhito Ota. Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver DiseaseBiomolecules 2015; 5(3): 1563 doi: 10.3390/biom5031563
238
Qingpu Liu, Xuan Li, Cunyu Li, Yunfeng Zheng, Fang Wang, Hongyang Li, Guoping Peng. 1-Deoxynojirimycin Alleviates Liver Injury and Improves Hepatic Glucose Metabolism in db/db MiceMolecules 2016; 21(3): 279 doi: 10.3390/molecules21030279
239
Marisa Carbonaro, Kehui Wang, Hui Huang, Davor Frleta, Aditi Patel, Alexander Pennington, Mathieu Desclaux, Sven Moller-Tank, Justin Grindley, Judith Altarejos, Jun Zhong, Greg Polites, William Poueymirou, Stephen Jaspers, Christos Kyratsous, Brian Zambrowicz, Andrew Murphy, John C. Lin, Lynn E. Macdonald, Christopher Daly, Mark Sleeman, Gavin Thurston, Zhe Li. IL-6–GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver modelsScience Advances 2023; 9(15) doi: 10.1126/sciadv.adf4490
240
Chien-Chao Chiu, Yung-Hao Ching, Yen-Peng Li, Ju-Yun Liu, Yen-Te Huang, Yi-Wen Huang, Sien-Sing Yang, Wen-Ching Huang, Hsiao-Li Chuang. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic SteatohepatitisNutrients 2017; 9(11): 1220 doi: 10.3390/nu9111220
241
Walid E. Zahran, Kholoud A. Salah El-Dien, Philip G. Kamel, Ahmed Shawky El-Sawaby. Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease ProgressionIndian Journal of Clinical Biochemistry 2013; 28(2): 141 doi: 10.1007/s12291-012-0236-5
242
Maryam K. Ibrahim, Robert M. Wilechansky, Prasanna K. Challa, Xuehong Zhang, Edward Giovannucci, Meir Stampfer, Andrew T. Chan, Tracey G. Simon. The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosisHepatology Communications 2023; 7(10) doi: 10.1097/HC9.0000000000000263
243
Xinyue Lin, Juanhong Zhang, Yajun Chu, Qiuying Nie, Junmin Zhang. Berberine prevents NAFLD and HCC by modulating metabolic disordersPharmacology & Therapeutics 2024; 254: 108593 doi: 10.1016/j.pharmthera.2024.108593
244
Bing-Hang Li, Fang-Ping He, Xin Yang, Yuan-Wen Chen, Jian-Gao Fan. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progressTranslational Research 2017; 180: 103 doi: 10.1016/j.trsl.2016.08.006
245
Noha I. Hussien, Hanan I. El-kerdasy, Mohammad El-tantawy Ibrahim. Protective effect of rimonabant, a canabinoid receptor 1 antagonist, on nonalcoholic fatty liver disease in a rat model through modulation of the hepatic expression of activin A and follistatinCanadian Journal of Physiology and Pharmacology 2017; 95(12): 1433 doi: 10.1139/cjpp-2017-0070
246
Thing-Fong Tzeng, Shorong-Shii Liou, Chia Ju Chang, I-Min Liu. [6]-Gingerol dampens hepatic steatosis and inflammation in experimental nonalcoholic steatohepatitisPhytomedicine 2015; 22(4): 452 doi: 10.1016/j.phymed.2015.01.015
247
Cheng‐Chung Li, Chun Liu, Maobin Fu, Kang‐Quan Hu, Koichi Aizawa, Shingo Takahashi, Suganuma Hiroyuki, Junrui Cheng, Johannes von Lintig, Xiang‐Dong Wang. Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in MiceMolecular Nutrition & Food Research 2018; 62(8) doi: 10.1002/mnfr.201700738
248
O. KUČERA, S. AL-DURY, H. LOTKOVÁ, T. ROUŠAR, D. RYCHTRMOC, Z. ČERVINKOVÁ. Steatotic Rat Hepatocytes in Primary Culture Are More Susceptible to the Acute Toxic Effect of AcetaminophenPhysiological Research 2012; : S93 doi: 10.33549/physiolres.932395
249
Tomasz Kostrzewski, Paloma Maraver, Larissa Ouro‐Gnao, Ana Levi, Sophie Snow, Alina Miedzik, Krista Rombouts, David Hughes. A Microphysiological System for Studying Nonalcoholic SteatohepatitisHepatology Communications 2020; 4(1): 77 doi: 10.1002/hep4.1450
250
Yue Zhang, Di Wang, Di Shen, Yang Luo, Yi-Qun Che. Identification of exosomal miRNAs associated with the anthracycline-induced liver injury in postoperative breast cancer patients by small RNA sequencingPeerJ 2020; 8: e9021 doi: 10.7717/peerj.9021
251
Ju Ho Park, Dong Hun Lee, Mork Soon Park, Young Suk Jung, Jin Tae Hong. C‐C chemokine receptor type 5 deficiency exacerbates alcoholic fatty liver disease through pro‐inflammatory cytokines and chemokines‐induced hepatic inflammationJournal of Gastroenterology and Hepatology 2017; 32(6): 1258 doi: 10.1111/jgh.13657
252
Charalambos Papadopoulos, Konstantinos Mimidis, Dimitris Papazoglou, George Kolios, Ioannis Tentes, Konstantinos Anagnostopoulos. Red Blood Cell-Conditioned Media from Non-Alcoholic Fatty Liver Disease Patients Contain Increased MCP1 and Induce TNF-α ReleaseReports of Biochemistry and Molecular Biology 2022; 11(1): 54 doi: 10.52547/rbmb.11.1.54
253
Min Cheol Kim, Kyeong OK Kim. Reply to “The causal association between sarcopenia and colorectal cancer: a Mendelian randomization analysis”The Korean Journal of Internal Medicine 2023; 38(2): 269 doi: 10.3904/kjim.2023.003
254
Manush Saydmohammed, Anupma Jha, Vineet Mahajan, Dillon Gavlock, Tong Ying Shun, Richard DeBiasio, Daniel Lefever, Xiang Li, Celeste Reese, Erin E Kershaw, Vijay Yechoor, Jaideep Behari, Alejandro Soto-Gutierrez, Larry Vernetti, Andrew Stern, Albert Gough, Mark T Miedel, D Lansing Taylor. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensorsExperimental Biology and Medicine 2021; 246(22): 2420 doi: 10.1177/15353702211009228